Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vachon

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Drug Development and Industrial Pharmacy|January 7, 1999
The use of particle characteristics to elucidate mix homogeneity in binary powder blendsM G Vachon, D Chulia
International Journal of Pharmaceutics|April 17, 1999
The use of energy indices in estimating powder compaction functionality of mixtures in pharmaceutical tabletingM G Vachon, D Chulia
Journal of Microencapsulation|May 1, 1997
The influence of microencapsulation using Eudragit RS100 on the hydrolysis kinetics of acetylsalicylic acidM G Vachon, J G Nairn
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 5, 1998
The use of 13C solid state NMR to elucidate physico-chemical association in Eudragit RS100 microencapsulated acyl esters of salicylic acidM G Vachon, J G Nairn
Journal of Microencapsulation|May 1, 1995
Physico-chemical evaluation of acetylsalicylic acid-Eudragit RS100 microspheres prepared using a solvent-partition methodM G Vachon, J G Nairn
Clinical Therapeutics|November 9, 2004
A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditionsPol-Henri Guivarc'h, Michael G Vachon, Diana Fordyce
FEBS Letters|April 26, 1993
Domain of E. coli translational initiation factor IF2 homologous to lambda cI repressor and displaying DNA binding activityG Vachon, J Raingeaud, B Dérijard, et al.
Drug Development and Industrial Pharmacy|April 3, 2002
Influence of manufacturing process on tabletting ability of powder: comparison between blending, grinding, and spray drying of two formulations made of theophylline and lactose/cellulose or CellactoseM Viana, B N'Dri-Stempfer, M G Vachon, et al.
Biochemistry|October 16, 1990
Purified internal G-domain of translational initiation factor IF-2 displays guanine nucleotide binding propertiesG Vachon, S Laalami, M Grunberg-Manago, et al.
Journal of Molecular Biology|May 5, 1992
Both forms of translational initiation factor IF2 (alpha and beta) are required for maximal growth of Escherichia coli. Evidence for two translational initiation codons for IF2 betaC Sacerdot, G Vachon, S Laalami, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Drug Development and Industrial Pharmacy|January 7, 1999
The use of particle characteristics to elucidate mix homogeneity in binary powder blendsM G Vachon, D Chulia
International Journal of Pharmaceutics|April 17, 1999
The use of energy indices in estimating powder compaction functionality of mixtures in pharmaceutical tabletingM G Vachon, D Chulia
Journal of Microencapsulation|May 1, 1997
The influence of microencapsulation using Eudragit RS100 on the hydrolysis kinetics of acetylsalicylic acidM G Vachon, J G Nairn
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 5, 1998
The use of 13C solid state NMR to elucidate physico-chemical association in Eudragit RS100 microencapsulated acyl esters of salicylic acidM G Vachon, J G Nairn
Journal of Microencapsulation|May 1, 1995
Physico-chemical evaluation of acetylsalicylic acid-Eudragit RS100 microspheres prepared using a solvent-partition methodM G Vachon, J G Nairn
Clinical Therapeutics|November 9, 2004
A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditionsPol-Henri Guivarc'h, Michael G Vachon, Diana Fordyce
FEBS Letters|April 26, 1993
Domain of E. coli translational initiation factor IF2 homologous to lambda cI repressor and displaying DNA binding activityG Vachon, J Raingeaud, B Dérijard, et al.
Drug Development and Industrial Pharmacy|April 3, 2002
Influence of manufacturing process on tabletting ability of powder: comparison between blending, grinding, and spray drying of two formulations made of theophylline and lactose/cellulose or CellactoseM Viana, B N'Dri-Stempfer, M G Vachon, et al.
Biochemistry|October 16, 1990
Purified internal G-domain of translational initiation factor IF-2 displays guanine nucleotide binding propertiesG Vachon, S Laalami, M Grunberg-Manago, et al.
Journal of Molecular Biology|May 5, 1992
Both forms of translational initiation factor IF2 (alpha and beta) are required for maximal growth of Escherichia coli. Evidence for two translational initiation codons for IF2 betaC Sacerdot, G Vachon, S Laalami, et al.
Pageof 2